Good News: Guangzhou Weiboxin Biotechnology’s “Classical Swine Fever Virus Blocking ELISA Antibody Detection Kit” Has Obtained a Veterinary Drug Product Approval Number.

发布时间:2024-06-19

Classical Swine Fever Virus Blocking ELISA Test Kit, Veterinary Drug Product Approval Number: Vet Drug Prod. No. 191438875

Good News! Guangzhou Weiboxin Biotechnology Co., Ltd. has achieved another breakthrough in the field of animal disease detection, successfully obtaining approval for the “Classical Swine Fever Virus Blocking ELISA Antibody Detection Kit.” ” The approval number for the veterinary drug product.

I. The Classical Swine Fever Virus Blocking ELISA Antibody Detection Kit Has Obtained an Approval Number

On June 5, 2024, in accordance with relevant provisions of the Regulations on the Administration of Veterinary Drugs and the Measures for the Administration of Approval Numbers for Veterinary Drug Products, Guangzhou Weiboxin Biotechnology Co., Ltd. launched the “Classical Swine Fever Virus Blocking ELISA Antibody Detection Kit.” ” , upon review, this product has been found to comply with the requirements and is approved for production. Veterinary Drug Product Approval Number: Veterinary Drug Production No. 191438875 This kit is a critical tool for detecting classical swine fever virus antibodies in serum and plays an important role in assessing the immune status of classical swine fever vaccines on pig farms as well as in the serological diagnosis of infected pigs. The approval of this kit signifies that the company’s R&D capabilities in the field of animal disease detection have been recognized by the Ministry of Agriculture and Rural Affairs.

II. Product Features and Advantages

1. High Sensitivity: This kit exhibits high sensitivity in sample detection, enabling rapid and accurate detection of classical swine fever virus antibodies in serum.

2. High specificity: This kit exhibits excellent specificity, enabling the specific detection of classical swine fever virus antibodies and thereby reducing the risk of false positives and false negatives.

3. Simple and convenient operation: This kit employs a competitive enzyme-linked immunosorbent assay (ELISA) principle for detection, offering simple and rapid procedures that make it suitable for use by animal disease prevention and control centers at all levels, customs authorities, and livestock farming enterprises.

4. Wide range of applications: This kit is widely applicable to animal disease prevention and control centers at all levels nationwide, customs authorities, livestock farms, food processing enterprises, third-party testing laboratories, research institutes, and other relevant organizations.

III. Company Background and Strength

Guangzhou Weiboxin Biotechnology Co., Ltd., a high-tech enterprise specializing in the R&D, manufacturing, sales, and technical services of diagnostic reagents for animal infectious diseases, is committed to advancing innovation and practical application of animal disease detection technologies. Headquartered in the national-level innovation park—Guangzhou Science City—the company is recognized as a “Contract-Honoring and Credit-Keeping Enterprise” by Guangdong Province and boasts strong technical capabilities and a team of top-tier professionals. To date, the company has obtained multiple veterinary drug product registration numbers from the Ministry of Agriculture and Rural Affairs and has achieved remarkable results in the field of animal disease diagnostics.

IV. Future Prospects

Guangzhou Weiboxin Biotechnology Co., Ltd. will continue to uphold the philosophy that “quality is life and innovation is the soul,” and remain committed to enhancing product quality and service standards. Leveraging a rapid and efficient research platform and abundant biomedical resources, the company will conduct extensive and in-depth R&D and scientific research in the biomedical field, thereby contributing to human health and advances in life sciences. At the same time, the company will strengthen exchanges and collaboration within the industry to jointly promote the development and application of animal disease detection technologies.